Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Pharm ; 615: 121496, 2022 Mar 05.
Article in English | MEDLINE | ID: mdl-35074436

ABSTRACT

Surfactants are commonly used in biotherapeutic formulations to prevent the formation of aggregates and protect proteins from denaturation. Among them polysorbates are the most widely used. However, they are known to be prone to degradation, mainly via enzymatic hydrolysis and oxidation. In this study, the impact of different conditions and factors on the oxidation of polysorbate 80 (PS80) and of a monoclonal antibody (mAb) was evaluated. In particular, the role of different formulation components (e.g., mAb concentration, pH, buffer, surfactant grade, chelators) was investigated in the presence of iron as transition metal contaminant. The results of our studies demonstrated that PS80 oxidation was accelerated even in the presence of iron levels as low as 20 ppb. In addition, the results showed that the oxidation of a specific solvent-exposed mAb methionine increased with PS80 oxidation, in particular under accelerated stress conditions and that the oxidation phenomenon was hindered in absence of iron or after addition of EDTA. Our results showed that PS80 "all oleate" (PS80-AO) was more sensitive to oxidative degradation than PS80 "multi-compendial" (PS80-MC). Contrary to acetate and citrate buffers, the results showed that the kinetics of PS80 oxidation was pH-dependent in presence of histidine buffer. It was also demonstrated that, when increasing its concentration, the mAb exhibited a protective effect against metal catalyzed PS80 and methionine oxidation. Our systematic studies on the role of the formulation components and potential contaminants (i.e., iron) demonstrated the complexity of the oxidative mechanism and the importance of different competitive systems, including pro-oxidant factors (e.g., iron, pH, PS80 quality) and antioxidant factors (e.g., protein concentration, EDTA, citrate) that may occur in biologic formulations containing PS80.


Subject(s)
Antibodies, Monoclonal , Polysorbates , Catalysis , Excipients , Oxidation-Reduction
2.
Talanta ; 240: 123174, 2022 Apr 01.
Article in English | MEDLINE | ID: mdl-35026643

ABSTRACT

This study details the development of on-line two-dimensional liquid chromatography (2D-LC) methods combining cation-exchange chromatography (CEX) and reversed-phase liquid chromatography (RPLC) for the separation of the charge variants of a lysine-linked antibody-drug conjugate (ADC). This combination gives an excellent example of the potential benefits of 2D-LC approaches for the analysis of such complex protein formats. CEX is considered the reference technique for the separation of protein charge variants but its retention mechanism usually requires the use of a high concentration of non-volatile salts, which impedes its compatibility with MS detection. In this context, the use of an on-line 2D-LC-MS approach not only allows on-line desalting and indirect coupling of CEX with mass spectrometry (MS) detection but it also provides increased and complementary information within a single analysis. The first part of this study was devoted to the choice of stationary phases and the optimization of chromatographic conditions in both dimensions. Based on the results obtained in 1D-CEX with ultraviolet detection (UV) and 1D-RPLC with UV and high-resolution mass spectrometry (HRMS) detections, an on-line comprehensive two-dimensional liquid chromatography method combining CEX and RPLC was developed. The last part of this study was devoted to the identification of the separated species using HRMS detection and in the comparison of three ADC samples exposed to different durations of thermal stress.


Subject(s)
Chromatography, Reverse-Phase , Immunoconjugates , Cations , Lysine , Mass Spectrometry
3.
J Chromatogr A ; 1536: 176-184, 2018 Feb 09.
Article in English | MEDLINE | ID: mdl-28923418

ABSTRACT

After demonstrating in a first paper the feasibility of SFCxSFC without decompression of the mobile phase, a modified interface has been developed in order to perform active modulation between the two SFC dimensions. In this paper, it is shown that the new interface enabled independent control of modulation parameters in SFCxSFC and performed a band compression effect of solutes between the two SFC dimensions. The effectiveness of this new modulation process was studied using a Design of Experiments. The SFCxSFC prototype was applied to the analysis of a real oil sample to demonstrate the benefits of the active modulator; in comparison to our previous results obtained without active modulation, better separation was obtained with the new interface owing to the peak compression occurring in the modulator.


Subject(s)
Carbon Dioxide/chemistry , Chemistry Techniques, Analytical/methods , Chromatography, Supercritical Fluid
4.
ACS Omega ; 2(9): 5962-5972, 2017 Sep 30.
Article in English | MEDLINE | ID: mdl-30023757

ABSTRACT

Early diagnosis of dopamine and serotonin metabolic defects is of importance notably because of the availability of therapeutic strategies able to prevent the associated progressive brain dysfunction. The diagnosis of these diseases relies on the determination of monoamine metabolites and pterins in cerebrospinal fluid (CSF). Current methods involve at least two high-performance liquid chromatography runs of CSF analysis. The first one is devoted to the quantification of dopamine and serotonin metabolites and the second one to the quantification of pterins. Here, we describe a single-step method to measure monoamine neurotransmitter metabolites and pterins of interest in less than 10 min by ultrahigh-performance liquid chromatography coupled to sequential coulometric oxidation and fluorescence detections. All target compounds were quantified in CSF with a small volume (50 µL) and a single filtration step for sample preparation and analysis. After validation, the proposed method was applied to the determination of age-related reference ranges in the CSF of target compounds from a series of 1372 samples collected in France from 2008 to 2014. In the same period, the results obtained for 19 CSF samples from patients with known neurotransmitter disorders and 115 CSF samples with known immune system activation confirmed the expected pattern of changes in monoamine metabolites and pterins.

5.
ACS Chem Neurosci ; 5(7): 533-41, 2014 Jul 16.
Article in English | MEDLINE | ID: mdl-24650440

ABSTRACT

In humans, genetic defects of the synthesis or regeneration of tetrahydrobiopterin (BH4), an essential cofactor in hydroxylation reactions, are associated with severe neurological disorders. The diagnosis of these conditions relies on the determination of BH4, dihydrobiopterin (BH2), and dihydroneopterin (NH2) in cerebrospinal fluid (CSF). As MS/MS is less sensitive than fluorescence detection (FD) for this purpose, the most widely used method since 1980 involves two HPLC runs including two differential off-line chemical oxidation procedures aiming to transform the reduced pterins into their fully oxidized fluorescent counterparts, biopterin (B) and neopterin (N). However, this tedious and time-consuming two-step indirect method underestimates BH4, BH2, and NH2 concentrations. Direct quantification of BH4 is essential for studying its metabolism and for monitoring the efficacy of BH4 supplementation in patients with genetic defects. Here we describe a single step method to simultaneously measure BH4, BH2, B, NH2, and N in CSF by HPLC coupled to FD after postcolumn coulometric oxidation. All target pterins were quantified in CSF with a small volume (100 µL), and a single filtration step for sample preparation and analysis. As compared to the most widely used method in more than 100 CSF samples, this new assay is the easiest route for accurately determining in a single run BH4, BH2, and NH2 in CSF in deficit situations as well as for monitoring the efficacy of the treatment.


Subject(s)
Biopterins/cerebrospinal fluid , Chromatography, High Pressure Liquid/methods , Neopterin/cerebrospinal fluid , Adult , Biopterins/analogs & derivatives , Child, Preschool , Female , Filtration , Fluorescence , Humans , Infant , Infant, Newborn , Light , Male , Mass Spectrometry , Metabolic Diseases/cerebrospinal fluid , Neopterin/analogs & derivatives , Nuclear Magnetic Resonance, Biomolecular , Time Factors , Ultraviolet Rays , Young Adult
6.
J Chromatogr A ; 1255: 252-8, 2012 Sep 14.
Article in English | MEDLINE | ID: mdl-22533910

ABSTRACT

The design and implementation of comprehensive two dimensional supercritical fluid chromatography (SFC) using neat carbon dioxide as the mobile phase is described. Two conventional supercritical fluid chromatographs were hyphenated via an on line comprehensive 2D liquid chromatography like interface; it consisted of a two loop switching valve allowing the collection of the first dimension column effluent, the second dimension separation of a fraction being performed during the time allowed for the collection of the subsequent fraction of the first dimension eluent. Both dimension separations were monitored via UV detection; for the second dimension, the main flow was diverted to implement flame ionisation detection for the detection of hydrocarbons and the construction of the corresponding colour plots. Some key parameters related to the interfacing of the two dimensions and the chromatographic conditions used in both dimensions are discussed. In this preliminary report, the feasibility of comprehensive 2D SFC is demonstrated on synthetic mixtures of hydrocarbons and its potential on real sample analysis is illustrated by the separation of coal derived vacuum distillate.


Subject(s)
Carbon Dioxide/chemistry , Chromatography, Supercritical Fluid/instrumentation , Chromatography, Supercritical Fluid/methods , Coal/analysis , Feasibility Studies , Hydrocarbons/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...